Nov 21, 2026 ยท 2026 #44. Read the transcript grouped by speaker, inspect word-level timecodes, and optionally turn subtitles on for direct video playback
Edit labels for this show, save them in this browser, or download a JSON override for the production folder.
Transcript Playback
The Rich Getting Richer
Human Transcript
Timed transcript
Blocks are grouped by speaker for readability. Expand a block to inspect word-level timing.
Speaker
[music]
Words and timings
No per-word timings found.
Keith Teare
this is Keith. It is Saturday, the 21st of November. I already published this week's That Was The Week yesterday. You will have received it if you're a subscriber, but I'm recording this video today so that There is a video and I'll update the online version to include it. First thing I should say is the subject matter today crosses over into my day job at SignalRank. And I want to say upfront that this is not a promotion of any kind. It is not a solicitation to try to interest you in investing in SignalRank. And I'm not asking you to invest in SignalRank. I am I'm cognizant of the fact that there are rules, including that you must be an accredited investor in order to invest in SignalRank. Unless you comply with those rules, I wouldn't be able to talk to you anyway. So this is on the topic of IPOs and who gets what. And it crosses over into the strategy that SignalRank employs. And that is about the size of it. So without further ado, Anthropic IPO'd this week. It was priced on Thursday at $83 a share. It closed that day just over $97 a share. And a day later closed again at around $89 a share. So if you bought at the IPO at $83, I did. I was able to get about 100 shares. You ended the day on Friday up about $6. If you bought on the first day of the IPO, the closing price, you ended up down about $6 or $7. And so the IPO was successful. It raised well over $90 billion at a valuation Several times during those two days, it went over $2 trillion of valuation. And the founders between them are now worth over $180 billion. So clearly, by any definition, this was a successful IPO. We'll see over the coming months how successful it is for the IPO buyers. But what I want to focus on is not the IPO itself, but the IPO is a window into how venture capital And public offerings work. And you'll see in the newsletter's editorial this week that Anthropic, over several years, since 2021, when it was first founded, has raised money consistently. And I focused in on the Series B round, the reason being that that is the round that SignalRank enters companies at. And at the Series B, the price per share of Anthropic was $1.12, which means that at $83, those who were selling at the IPO will have had a multiple of their original investment, well over 70 times their original investment, very different to the 14% gain that IPO buyers would get. So for approximately a billion dollars was raised to that Series B round, initially 580 million and then it ended up at 980 million dollars. So roughly a billion dollars was raised and that turned into a valuation of well over 80 billion dollars. Let that sink in for a moment. A billion dollars turned into about 80 billion dollars. Contrast that with the 80 plus billion dollars it cost buyers to buy the IPO that turned into something like 87 billion dollars. So clearly when you enter a venture-backed company really matters, especially for a successful one. Now it is worth saying at series B, Something like one in 10 companies are successful. So it is not a de-risked stage of venture capital and there's a chance you will lose your money. And for that reason, the SEC doesn't let retail investors buy private stocks unless they are what is called accredited investors. The definition of that is very clear. You need to have $200,000 a year of income, or if you're a couple, $300,000, or a million dollars of liquid net worth, not including your home. And if you comply with those, you're an accredited investor, and if you can get access to a company, you can invest in it. The problem is, of course, you almost can never get access to these companies. These are highly contested funding rounds in high growth companies that mostly professional investors get into. So the B round was a fantastic entry point compared to what IPO investors paid. All of that money from the IPO goes to the company. Minus the portion which selling investors took out, which was a small portion of the IPO. Most of the money will go to the company to spend on growth. And Anthropic now has, I think, over $200 billion of cash on its books for the next phase of its growth. Now, it's worth saying that in recent times, most value growth For companies happens during their private stage. So Anthropic is not unusual, except on the scale is unusual, but the pattern is not. People invest during the private phase. And by the time an IPO happens, which is increasingly rare, most of the growth in value is already locked in. And indeed, there's often IPO risk. Most recent IPOs have declined from the IPO price over the subsequent period. Some recover, some don't. But clearly the IPO is not a great point to get in. That means there's a scramble. There's generally speaking a scramble to get into these companies. And you'll find that scramble in the secondary venture markets. Companies like Clarity, used to be called Hive, or Forge Global, or the NASDAQ private markets, which organizes tender offers for private stocks. Make shares available in secondary markets and there's been a scramble to own those shares, often at prices that are hard to understand and in structures that are pretty opaque. You really don't know what it is you own, but there's been a lot of controversy around that. This secondary market frenzy, it's growing a lot, is driven by interest in private companies. The Anthropic IPO shows you why, because if you can get into a company early, you will clearly, if the company is successful, do way better than getting in late. So the secondary markets are alert and alive to that fact and are growing. The problem is, of course, that these secondary markets are highly unstructured. There are a lot of what are now publicly listed venture companies like Destiny Tech 100, PowerLaw, Fundrise, and Robinhood Ventures that are buyers of secondary shares that then list and have sold their shares to the public. Holding a basket of assets which are late stage venture assets. So why am I telling you this? Well, basically the entire system is broken in all kinds of ways. The demand to own private growth companies is clearly there. The restrictions on being able to are clearly there. And in order to get around those restrictions, secondary markets have emerged, which frankly I don't think do a favor to private investors. They are often left holding the bag. So what my editorial argues for this week is a more structured approach to private access and public liquidity. Combining owning high growth private companies with the ability to sell your shares whenever you want in a public market. And to do that, you need what I call one level of indirection, one level above the private market. What does that mean? It means that funds should start acquiring High growth private stocks like SignalRank does at Series B. SignalRank has 68 B round companies in its portfolio. Some of them are already at eight times the money paid by SignalRank, five times, four times in a relatively short period of time. So funds should buy these private assets early. I strongly believe Series B is the right entry point because it's very de-risk. Those funds should be listed on the stock market so that retail investors can own, indirectly own, the basket of companies from the stage that the fund enters at. In the case of SignalRank, that's the Series B stage. And when those companies grow an IPO, have the benefit that In the last two days, private investors saw in Anthropic the 70-something times multiple of their original investment for Series B investors, 377 times their investment for A round investors. That kind of growth should be available to retail investors without undermining the rules around accredited investors. And the way to do that is to create a public wrapper that Fund around these private assets where the public is allowed to invest. Of course, then you need to de-risk what is in the basket. And there are now quite a number of public wrappers. Some are more de-risk than others. I would argue that B round entry is highly de-risked. But if you're buying secondary shares prior to an IPO, it's very risky and there's downside risk. So that's up to each investor to determine how they want to play it. But clearly, this rich getting richer is a structural reality based on the way that venture capital works. And to fix it, you need to make High growth venture companies available to retail investors via a regulated compliant vehicle. And that is what I believe in. And that's what the editorial this week is all about. So with that said, go read the editorial. I'll add this video to the published version of the newsletter. And see you all next week. Bye.